Search
for
Sort by
Research 361–390 of 1000+
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers
- Menopause
- Androgen treatment in women
- Polycystic ovary syndrome
- S100A6 Protein—Expression and Function in Norm and Pathology
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Alopecia and hirsutism*
- Polycystic Ovary Syndrome (PCOS): From Diagnosis to Treatment
- Hair, Hormones, and High-Risk Prostate Cancer
- Polycystic Ovary Syndrome
- Insulin Resistance and Polycystic Ovary Syndrome
- Male-pattern hair loss: Comprehensive identification of the associated genes as a basis for understanding pathophysiology
- Conditioned Medium from Human Mesenchymal Stromal Cells: Towards the Clinical Translation
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- Recent Trends and Future Prospects of Phytosomes: A Concise Review
- Synthesis of 11α-hydroxyprogesterone hartens
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- Current Progress Regarding Cordyceps militaris, Its Metabolite Function, and Its Production
- Influence of conditioned media from glial cell cultures on contractility of uterine in rats of different ages
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- Drug Repurposing Patent Applications July–September 2025
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Actualités du SOPK
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Polycystic Ovary Syndrome
- Protection Against Chemotherapy-Induced Alopecia
- Alopecia With Endocrine Therapies in Patients With Cancer
- Androgen antagonists in androgen target tissues